FYI - For Your Innovation cover image

Optogenetics, RNA Editing and CRISPR with Dr. Feng Zhang

FYI - For Your Innovation

00:00

Arne Editing

Arne is transient, so maybe the risk is n asbig therey. It may be advantageous touse arna editing for things that only require transient treatment. But for longer term treatment with arnedin, you will have to give multiple doses to the drug. Then other considerations come in: Does the arneedidy molecule become munogenic? Is it well tolerated by the body over multiple courses of treatment? So those are things that will also have to be understood. There are certainly a lot of exciting and promising result that is really encouraging. And i think we're going to continue develop it,. I'm hopeful that this will become something that will benefit a lot of people.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app